Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18

Antiviral Research

Volumn 91, Issue 1, 2011, Pages 50-56

  Chen, Hong Ying ^a   Shang, Yan Hong ^a   Yao, Hui Xia ^a   Cui, Bao An ^a   Zhang, Hong Ying ^a   Wang, Zi Xin ^a   Wang, Ya Dan ^a   Chao, An Jun ^a   Duan, Ting Yun ^b  

^a HENAN AGRICULTURAL UNIVERSITY   (China)

^b LuoHe Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Chicken interleukin 18 gene; H9N2 avian influenza virus; Hemagglutinin gene; Recombinant fowlpox virus

Indexed keywords

HEMAGGLUTININ; INTERLEUKIN 18; RECOMBINANT FOWLPOX VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CHICKEN; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FIBROBLAST; FOWLPOX; FOWLPOX VIRUS; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA VIRUS A H9N2; NONHUMAN; PLASMID; PRIORITY JOURNAL; SPLEEN CELL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; FOWLPOX; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INTERLEUKIN-18; RNA POLYMERASE III; VACCINES, SYNTHETIC; VIRAL VACCINES;

ANIMALIA; AVIAN INFLUENZA VIRUS; FOWLPOX VIRUS; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 79957571820     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.04.007     Document Type: Article

References (39)

1. Alexander D.J. An overview of the epidemiology of avian influenza. Vaccine 2007, 26:5637-5644.
2. Bolte L., Meurer J., Kaleta E.F. Avian host spectrum of avipoxviruses. Avian Pathol. 1999, 28:415-432.
3. Boyle D.B., Coupar B.E. Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Res. 1988, 10:343-356.
4. Brown D.W., Kawaoka Y., Webster R.G., Robinson H.L. Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. Avian Dis. 1992, 36:515-520.
5. Butt K.M., Smith G.J., Chen H., Zhang L.J., Leung Y.H., Xu K.M., Lim W., Webster R.G., Yuen K.Y., Peiris J.S., Guan Y. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J. Clin. Microbiol. 2005, 43:5760-5767.
6. Butter C., Sturman T.D., Baaten B.J., Davison T.F. Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2. Avian Pathol. 2003, 32:597-604.
7. Chambers T.M., Kawaoka Y., Webster R.G. Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin. Virology 1988, 167:414-421.
8. Chen H.Y., Cui B.A., Xia P.A., Li X.S., Hu G.Z., Yang M.F., Zhang H.Y., Wang X.B., Cao S.F., Zhang L.X., Kang X.T., Tu K. Cloning, in vitro expression and bioactivity of duck interleukin-18. Vet. Immunol. Immunopathol. 2008, 123:205-214.
9. Choi J.G., Lee Y.J., Kim Y.J., Lee E.K., Jeong O.M., Sung H.W., Kim J.H., Kwon J.H. An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea. J. Vet. Sci. 2008, 9:67-74.
10. Dinarello C.A., Fantuzzi G. Interleukin-18 and host defense against infection. J. Infect. Dis. 2003, 187:S370-S384.
11. Edwards S. OIE laboratory standards for avian influenza. Dev. Biol. (Basel) 2006, 124:159-162.
12. Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., Osterhaus A.D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 2005, 79:2814-2822.
13. Ge J., Tian G., Zeng X., Jiang Y., Chen H., Bua Z. Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine. Avian Dis. 2010, 54:294-296.
14. Gracie J.A., Robertson S.E., McInnes I.B. Interleukin-18. J. Leukoc. Biol. 2003, 73:213-224.
15. Homme P.J., Easterday B.C. Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus. Avian Dis 1970, 14:66-74.
16. Hunt L.A., Brown D.W., Robinson H.L., Naeve C.W., Webster R.G. Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J. Virol. 1988, 62:3014-3019.
17. Kim J.A., Cho S.H., Kim H.S., Seo S.H. H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers. Vet. Microbiol. 2006, 118:169-176.
18. Kishida N., Sakoda Y., Eto M., Sunaga Y., Kida H. Co-infection of Staphylococcus aureus or Haemophilus paragallinarum exacerbates H9N2 influenza A virus infection in chickens. Arch Virol. 2004, 149:2095-2104.
19. Leong K.H., Ramsay A.J., Boyle D.B., Ramshaw I.A. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J. Virol. 1994, 68:8125-8130.
20. Li C., Yu K., Tian G., Yu D., Liu L., Jing B., Ping J., Chen H. Evolution of H9N2 influenza viruses from domestic poultry in Mainland China. Virology 2005, 340:70-83.
21. Liu J.H., Okazaki K., Mweene A., Shi W.M., Wu Q.M., Su J.L., Zhang G.Z., Bai G.R., Kida H. Genetic conservation of hemagglutinin gene of H9 influenza virus in chicken population in Mainland China. Virus Genes 2004, 29:329-334.
22. Lin Y.J., Deng M.C., Wu S.H., Chen Y.L., Cheng H.C., Chang C.Y., Lee M.S., Chien M.S., Huang C.C. Baculovirus-derived hemagglutinin vaccine protects chickens from lethal homologous virus H9N2 challenge. J. Vet. Med. Sci. 2008, 70:1147-1152.
23. Marshall D.J., Rudnick K.A., McCarthy S.G., Mateo L.R., Harris M.C., McCauley C., Snyder L.A. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 2006, 24:244-253.
24. Mingxiao M., Ningyi J., Zhenguo W., Ruilin W., Dongliang F., Min Z., Gefen Y., Chang L., Leili J., Kuoshi J., Yingjiu Z. Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 2006, 24:4304-4311.
25. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 2001, 19:423-474.
26. Ninomiya A., Takada A., Okazaki K., Shortridge K.F., Kida H. Seroepidemiological evidence of avian H4, H5, and H9 influenza A virus transmission to pigs in southeastern China. Vet. Microbiol. 2002, 88:107-114.
27. Oh H.L., Akerström S., Shen S., Bereczky S., Karlberg H., Klingström J., Lal S.K., Mirazimi A., Tan Y.J. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H9N2 influenza viruses. J. Virol. 2010, 84:8275-8286.
28. Pan Z., Zhang X., Geng S., Cheng N., Sun L., Liu B., Huang J., Jiao X. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 2009, 27:1018-1023.
29. Park K.J., Kwon H.I., Song M.S., Pascua P.N., Baek Y.H., Lee J.H., Jang H.L., Lim J.Y., Mo I.P., Moon H.J., Kim C.J., Choi Y.K. Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J. Gen. Virol. 2011, 92:36-50.
30. Peiris M., Yuen K.Y., Leung C.W., Chan K.H., Ip P.L., Lai R.W., Orr W.K., Shortridge K.F. Human infection with influenza H9N2. Lancet 1999, 354:916-917.
31. Qiao C., Jiang Y., Tian G., Wang X., Li C., Xin X., Chen H., Yu K. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus. Antiviral Res. 2009, 81:234-238.
32. Song J.M., Lee Y.J., Jeong O.M., Kang H.M., Kim H.R., Kwon J.H., Kim J.H., Seong B.L., Kim Y.J. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea. Vet. Microbiol. 2008, 130:268-276.
33. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410.
34. Sun H.L., Wang Y.F., Tong G.Z., Zhang P.J., Miao D.Y., Zhi H.D., Wang M., Wang M. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus. Avian Dis. 2008, 52:111-117.
35. Swayne D.E., Beck J.R., Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 2000, 44:132-137.
36. Wang Y.F., Sun Y.K., Tian Z.C., Shi X.M., Tong G.Z., Liu S.W., Zhi H.D., Kong X.G., Wang M. Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNgamma. Vaccine 2009, 27:7046-7052.
37. Xu C.T., Fan W.X., Rong W., Zhao H.K. Isolation and identification of swine influenza recombinant A/Swine/Shandong/1/2003(H9N2) virus. Microbes Infect. 2004, 6:919-925.
38. Yin R.L., Li C., Yang Z.T., Zhang Y.J., Bai W.L., Li X., Yin R.H., Liu H., Liu S., Yang Q., Cao Y.G., Zhang N.S. Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18. Vet. Immunol. Immunopathol. 2009, 132:270-274.
39. Zhu M., Xu X., Liu H., Liu X., Wang S., Dong F., Yang B., Song G. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant. J. Med. Microbiol. 2003, 52:223-228.